MIR22HG was reported to decrease in HCC tissues and predict the poor prognosis of HCC patients, as it functions as a tumor suppressor and inhibits cell proliferation and invasion by sponging miRNA-10a-5p to upregulate nuclear receptor co-repressor 2 (NCOR2) expression [67]. This evidence concerns the gene MIR22HG and hepatocellular carcinoma.